Glioma: Immunotherapeutic Approaches

· Springer Science & Business Media
5.0
리뷰 1개
eBook
232
페이지
검증되지 않은 평점과 리뷰입니다.  자세히 알아보기

eBook 정보

Treatment of glioma is currently one of the most challenging problems in oncology, as well as in neurosurgery. Despite major advances in our understanding of the pathomechanism, diagnosis by imaging and the availability of powerful therapeutic tools, the life expectancy of patients with glioblastoma has only been slightly prolonged and a cure remains elusive. None of the currently available surgical tools, including operative microscopes, lasers and image-guided surgery, can enable the detection and removal of all of the tumor tissue. In recent years, however, the landscape has been changing immeasurably, and molecular studies over the past two decades have identified a variety of genetic aberrations that are specifically associated with individual types of gliomas. In addition, certain molecular abnormalities have been linked to therapy responses, thereby establishing clinical biomarkers and molecular targets, and the use of novel agents is being investigated. These agents have been specifically engineered to exert specific cytotoxicity against gliomas, either on their own as single agents or in combination with other modalities. Moreover, there has been an enormous surge of interest in the area of immunology and immunotherapy, which has been facilitated by our understanding of the molecular basis of gliomas. Although several kinds of immunotherapeutic trials have been undertaken, we still await a great breakthrough in terms of clinical efficacy to prolong the survival time of glioma patients.

평점 및 리뷰

5.0
리뷰 1개

저자 정보

RYUYA YAMANAKA is now a Professor at Kyoto Prefectural University of Medicine, Kyoto, Japan. He earned his MD at Niigata University, Japan, in 1982 and completed a neurosurgical residency training at its affiliated hospitals. He received his academic degree (Dr Med Sci) from Niigata University. Following research fellowships at the National Institutes of Health in the United States from 1994 to 1998, he assumed the position of Assistant Professor and Lecturer at the Department of Neurosurgery in the Brain Research Institute at Niigata University. In 2006, he was promoted to Professor of the Research Center of Innovative Cancer Therapy at Kurume University School of Medicine. He joined the faculty at Kyoto Prefectural University of Medicine in 2010. His main research interests include translational biochemical research in clinical oncology, including brain tumors. He is a member of international and national scientific organizations, including the American Association for Cancer Research (AACR ), American Society of Clinical Oncology (ASCO), Japanese Cancer Association (JCA), Japanese Society of Medical Oncology (JSMO) and Japan Neurosurgical Society (JNS). He has board certifications for Medical Oncology, Neurosurgery, Stroke and Cerebrovascular Diseases.

이 eBook 평가

의견을 알려주세요.

읽기 정보

스마트폰 및 태블릿
AndroidiPad/iPhoneGoogle Play 북 앱을 설치하세요. 계정과 자동으로 동기화되어 어디서나 온라인 또는 오프라인으로 책을 읽을 수 있습니다.
노트북 및 컴퓨터
컴퓨터의 웹브라우저를 사용하여 Google Play에서 구매한 오디오북을 들을 수 있습니다.
eReader 및 기타 기기
Kobo eReader 등의 eBook 리더기에서 읽으려면 파일을 다운로드하여 기기로 전송해야 합니다. 지원되는 eBook 리더기로 파일을 전송하려면 고객센터에서 자세한 안내를 따르세요.